Dal Negro RW1*, Turco P2 and Santin G3
1National Centre of Pharmacoeconomics and Pharmacoepidemiology - CESFAR - Verona, Italy 2Research and Clinical Governance, Verona, Italy 3Ophtalmologic Unit, San Donà di Piave General Hospital - Veneto Orientale, ItalyFulltext PDF
The clinical impact of SARS-CoV-2-induced disease (COVID-19) recognizes different severity in adults. SARS-CoV-2 infection also involves the eyes, and acute conjunctivitis represents the most frequently ocular manifestation currently reported. We present a clinical case of ocular venous thrombosis observed in a healthy woman affected with a pauci-symptomatic COVID-19, occurred during the pandemic peak. SARS-CoV-2 infection was confirmed by nasopharyngeal swab and IgG serology. Further to acute conjunctivitis, venous thrombotic events should be included in the list of possible ocular COVID-19 manifestations. COVID-19 -induced viral tissue damage, hypercoagulability, and dysregulation of immune response likely represent the main pathogenetic determinants of this severe ocular complication.
COVID-19; Atypical manifestations; Eyes; Conjunctivitis; Ocular venous thrombosis
Dal Negro RW, Turco P, Santin G. Ocular Venous Thrombosis as the Main Manifestation of an Otherwise Pauci- Symptomatic COVID-19. Clin Case Rep Int. 2020; 4: 1176.